ARCHIVES

October issue of Business & Regulatory Report included.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.

October 26, 2001

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

March 3, 2000

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

In Brief: fraud By Trainee Leads Collins To Retract Five Paper; Weinstein Retires At Columbia

November 1, 1996